MedTrace Logo

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

NCT01467791 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-12-08

No results posted yet for this study

Summary

Registry to follow patients with sarcoidosis associated pulmonary hypertension

Conditions

  • Sarcoidosis
  • Pulmonary Hypertension

Interventions

OTHER

Observation

Observe patients

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Robert P Baughman, MD · University of Cincinnati

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2017-01-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01467791 on ClinicalTrials.gov